Carbidopa
Carbidopa is a pharmaceutical drug with 20 clinical trials. Currently 1 active trials ongoing. Historical success rate of 94.4%.
Success Metrics
Based on 17 completed trials
Phase Distribution
Phase Distribution
9
Early Stage
7
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
94.4%
17 of 18 finished
5.6%
1 ended early
1
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of 5HTP on the Injured Human Spinal Cord
Neurobiological Drivers of Mobility Resilience: The Dopaminergic System
Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With Fibromyalgia
Effects of 5HTP and LDOPA on CNS Excitability After SCI
Peripheral Dopamine in Postural Tachycardia Syndrome
Clinical Trials (20)
Effects of 5HTP on the Injured Human Spinal Cord
Neurobiological Drivers of Mobility Resilience: The Dopaminergic System
Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With Fibromyalgia
Effects of 5HTP and LDOPA on CNS Excitability After SCI
Peripheral Dopamine in Postural Tachycardia Syndrome
Dose-finding Pharmacokinetic Study in Healthy Males
Histaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel Approach
Norepinephrine-targeted Therapy for Action Control in Parkinson Disease
High and Low Dose Carbidopa Treatment of Parkinson's Disease
Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)
Treatment of Supine Hypertension in Autonomic Failure
A Study of the Safety and Levodopa Pharmacokinetics Following Single Dose Administration of CVT 301 (Levodopa Inhalation Powder) in Smoking and Non-Smoking Adults
A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma
Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia
Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence
Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.
Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon
Augmenting Effects of L-DOPS With Carbidopa and Entacapone
A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease Patients
Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens
All 20 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 20